ENHANCED ROLLER BOTTLE

Information

  • Research Project
  • 6552066
  • ApplicationId
    6552066
  • Core Project Number
    R44GM058978
  • Full Project Number
    2R44GM058978-02A1
  • Serial Number
    58978
  • FOA Number
  • Sub Project Id
  • Project Start Date
    2/1/1999 - 25 years ago
  • Project End Date
    7/31/2004 - 19 years ago
  • Program Officer Name
    SWAIN, AMY L
  • Budget Start Date
    8/1/2002 - 21 years ago
  • Budget End Date
    7/31/2003 - 20 years ago
  • Fiscal Year
    2002
  • Support Year
    2
  • Suffix
    A1
  • Award Notice Date
    7/26/2002 - 21 years ago

ENHANCED ROLLER BOTTLE

DESCRIPTION (provided by applicant)Advances in large-scale production of mammalian cells or their secreted proteins have led to the licensure of many therapeutic and diagnostic products. Culture devices, such as stirred-tank and hollow fiber bioreactors, have utility in large-scale production, but are impractical and cost prohibitive at the research scale. Traditional roller bottles have been used successfully for small to mid-scale production of recombinant proteins, viral vectors, and therapeutic cell doses, but are labor intensive, typically requiring more than ten devices for each desired product. The Enhanced Roller Bottle (ERB) is a practical, cost effective cell culture device designed to improve culture productivity. The ERB increased cell production 4- to 9-fold over the traditional roller bottle by increased surface area for cell attachment and increased availability of culture medium due to its gas permeable walls. In the proposed Phase II studies, the ERB will be optimized for the production of anchorage-dependent cells and cell-secreted products. ERB parameters requiring investigation include gas transfer, scaffold configuration and material, inoculation methods, operating conditions, and product recovery. At the completion of Phase II, the ERB will be targeted to manufacturers of small and mid-scale culture devices for the production of cells or cell products for diagnostic and therapeutic applications.

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    R44
  • Administering IC
    GM
  • Application Type
    2
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    527249
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    821
  • Ed Inst. Type
  • Funding ICs
    NIGMS:527249\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    WILSON WOLF MANUFACTURING CORPORATION
  • Organization Department
  • Organization DUNS
  • Organization City
    NEW BRIGHTON
  • Organization State
    MN
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    55112
  • Organization District
    UNITED STATES